Evaluating ABX-EGF Monotherapy in Subjects With Metastatic Colorectal Cancer Following Treatment With Fluoropyrimidine, Irinotecan, and Oxaliplatin Chemotherapy
This study is ongoing, but not recruiting participants.
Study NCT00083616
Information provided by Amgen
First Received: May 26, 2004
Last Updated: November 19, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
